Navigation Links
Blue Dye Halts Worsening Paralysis in Animal Study

Discovery could lead to new treatments for people with spine injuries

TUESDAY, July 28 (HealthDay News) -- The food additive that makes M&Ms and Gatorade blue may help prevent the secondary damage that occurs after a spinal cord injury, a new study suggests.

Researchers say that the dye, called Brilliant Blue G (BBG), stops the cascade of molecular events that can expand the area of injury and permanently worsen paralysis.

This finding builds on landmark research that detailed how ATP, the vital energy source that keeps the body's cells alive, pours into the area around a spinal cord injury, killing off healthy and uninjured cells. This previous research also laid out a potential way to stop secondary spinal injury: use oxidized ATP to block the ATP, according to background information provided in a news release from the University of Rochester.

Rats with damaged spinal cords that were injected with oxidized ATP recovered much of their limb function and were able to effectively, if not gracefully, walk again, the earlier research found.

The new study has found a compound that does the same thing, and it doesn't have to be injected directly into the injured spinal cord to work, the study authors explain in their report, published online in this week's issue of the Proceedings of the National Academy of Sciences.

"While we achieved great results when oxidized ATP was injected directly into the spinal cord, this method would not be practical for use with spinal cord-injured patients," said lead researcher Dr. Maiken Nedergaard, a professor of neurosurgery and director of the Center for Translational Neuromedicine at the University of Rochester Medical Center.

"First, no one wants to put a needle into a spinal cord that has just been severely injured, so we knew we needed to find another way to quickly deliver an agent that would stop ATP from killing healthy motor neurons. Second, the compound we initially used, oxidized ATP, cannot be injected into the bloodstream because of its dangerous side effects," Nedergaard explained in the news release.

In the search for a compound that would thwart ATP attacks and could be administered intravenously, Nedergaard stumbled upon BBG.

An intravenous injection of BBG significantly reduced secondary injury in spinal cord-injured rats, which improved to the point of being able to walk again, although with a limp. There was a side effect, however. Injected rats had a blue tinge to their skin for a while.

While more study is needed, Nedergaard and longtime collaborator Dr. Steven Goldman, chair of the University of Rochester Department of Neurology, hope that BBG and related agents will yield new treatments for acute spinal cord injuries.

More information

The U.S. National Institutes of Health offers information on spinal cord injuries.

--Dennis Thompson

SOURCE: University of Rochester, news release, July 27, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Photo: New Data Show Gleevec(R) Halts Progression to Advanced Stages of Life-Threatening Form of Leukemia in Sixth Year of Treatment
2. Scripps research scientists find new genetic mutation that halts the development of lupus
3. Experimental Vaccine Halts Prostate Cancer in Mice
4. Manufacturer Halts Production of Blood Thinner Heparin
5. St. Jude finds signaling system that halts the growth of a childhood brain cancer
6. Surgical technique halts cell loss, Parkinsons researchers find
7. PA Department of Health Halts Admissions at Commonwealth Medical Center in Beaver County
8. Gastric Bypass Halts Diabetes in Obese Teens
9. Kellogg Halts Sales of Peanut Butter Crackers
10. FDA Halts New Applications From Indian Drug Makers Plant
11. Interferon does not slow or stop hepatitis C from worsening, study finds
Post Your Comments:
Related Image:
Blue Dye Halts Worsening Paralysis in Animal Study
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare ... IT Healthcare was recognized as a finalist in the category of Digital Solutions ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... 01, 2015 , ... PYA’s latest white paper, “ PYA ... main “pain point” for merging or aligning healthcare provider organizations—when mergers and other ... This quick-read guidance suggests that failing to recognize the power of an ...
(Date:12/1/2015)... ... 2015 , ... PartnerTech , a leader in high-tech ... 2008. Gary Bruce, President of PartnerTech North America, currently serves as Director for ... of time in Sweden since joining PartnerTech based in Malmo, Sweden. He has ...
(Date:12/1/2015)... ... December 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker of ... to date. , The order will be from the China Disabled Persons’ Federation, ... System is an effective solution for children and adults suffering from severe and ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... India , December 1, 2015 ... market research report "Immunotherapy Drugs Market by Type of Drug ... Checkpoint Inhibitors), Epidemiology, Regulatory and Pipeline Analysis - Global Forecast ... is poised to reach USD 73,529.2 Million by 2020 from ... from 2015 to 2020. Browse 37 ...
(Date:12/1/2015)... , 1 de diciembre de 2015 /PRNewswire/ ... para cuchillas de precisión, develó hoy un ... identidad de marca. El nuevo logo destaca ... y la ingeniería de productos con cuchillas ... ...
(Date:12/1/2015)... 2015 During the recent 2015 Transcatheter ... Francisco, CA , Medinol Ltd. continued to ... During a satellite symposium, "The BioNIR eDES: The ... Restenosis", a renowned physician panel discussed the key ... Coronary Stent System and the Medinol eDES Coronary ...
Breaking Medicine Technology: